Status:

COMPLETED

Interbody Fusion Devices in the Treatment of Cervicobrachial Syndrome

Lead Sponsor:

Amedica Corporation

Conditions:

Radiating Pain

Myelopathy

Eligibility:

All Genders

18-75 years

Phase:

NA

Brief Summary

This study randomizes neck and arm pain patients being treated with discectomy and anterior interbody fusion into two groups: one to receive a new ceramic implant and a control group with a more tradi...

Eligibility Criteria

Inclusion

  • Age 18 75 years
  • Radicular signs and symptoms in one or both arms (i.e., pain, paraesthesiae or paresis in a specific nerve root distribution) or symptoms and signs of acute or chronic myelopathy.
  • At least 8 weeks prior conservative treatment (i.e., physical therapy, pain medication)
  • Radiographic diagnosis of cervical disc herniation and/or osteophyte at 1 level (C3-C4 to C7-T1) in accordance with clinical signs and symptoms
  • Ability and willingness to comply with project requirements
  • Written informed consent given by the subject or the subject's legally authorised representative

Exclusion

  • Previous cervical surgery (either anterior or posterior)
  • Increased motion on dynamic studies (\> 3 mm)
  • Severe segmental kyphosis of the involved disc level (\> 7 degrees)
  • Patient cannot be imaged with MRI
  • Neck pain only (without radicular or medullary symptoms)
  • Infection
  • Metabolic and bone diseases (osteoporosis, severe osteopenia)
  • Neoplasma or trauma of the cervical spine
  • Spinal anomaly (Klippel Feil, Bechterew, OPLL)
  • Severe mental or psychiatric disorder
  • Inadequate Dutch language
  • Planned (e)migration abroad in the year after inclusion

Key Trial Info

Start Date :

December 1 2011

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 1 2015

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT01511445

Start Date

December 1 2011

End Date

November 1 2015

Last Update

May 8 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Medical Center Haaglanden

The Hague, Netherlands, 2501 CK